TScan Therapeutics, Inc. (TCRX)
0.2377
+0.03
(+12.87%)
USD |
NASDAQ |
Oct 15, 16:00
0.2377
0.00 (0.00%)
After-Hours: 20:00
TScan Therapeutics Total Assets (Quarterly) : 171.45M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 171.45M |
| March 31, 2026 | 201.99M |
| December 31, 2025 | 228.79M |
| September 30, 2025 | 262.22M |
| June 30, 2025 | 298.56M |
| March 31, 2025 | 332.71M |
| December 31, 2024 | 371.12M |
| September 30, 2024 | 348.03M |
| June 30, 2024 | 374.87M |
| March 31, 2024 | 240.83M |
| December 31, 2023 | 272.15M |
| Date | Value |
|---|---|
| September 30, 2023 | 291.38M |
| June 30, 2023 | 316.92M |
| March 31, 2023 | 173.58M |
| December 31, 2022 | 199.09M |
| September 30, 2022 | 165.45M |
| June 30, 2022 | 152.42M |
| March 31, 2022 | 168.20M |
| December 31, 2021 | 188.11M |
| September 30, 2021 | 204.89M |
| June 30, 2021 | 130.01M |
| March 31, 2021 | 140.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
| Anika Therapeutics, Inc. | 183.47M |
| BioCryst Pharmaceuticals, Inc. | 557.85M |
| Imunon, Inc. | 14.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 102.43M |
| Shareholders Equity (Quarterly) | 69.02M |
| Debt to Equity Ratio | 1.317 |
| Current Ratio | 3.372 |
| Net Debt Paydown Yield | 1.85% |